US equities |
MU $1,083.65 ▲+3.64% NVDA $237.07 ▼-0.90% SNDK $1,704.44 ▲+2.65% SPCX $167.51 ▼-2.57% AMD $640.65 ▼-1.35% TSLA $377.82 ▼-0.75% INTC $112.65 ▲+0.13% AAPL $337.25 ▲+1.09%
FinancialContent

Latest News about Alpha Cognition

Recent news which mentions Alpha Cognition

Alpha Cognition's latest financial growth highlighted by new listing on Canadian Stock Exchange
Tags OTCB:ACOGF XCNQ:ACOG Alpha Cognition
From TheNewswire.com - RSS (Media)
Alpha Cognition Attracts New Investors as Future Leader in Growing Alzheimer's Disease Market
Tickers ACOGF
Tags ACOGF General Benzinga
From Benzinga
New Alzheimer's Disease Drug Candidate with Dual Mode of Action May Show Decreased Side Effects in Clinical Trials
Tags Biotech Health Care Market News
From Benzinga
Controversy Surrounding Aduhelm's Approval Leads Researchers to Rethink Long Standing Hypothesis Driving Alzheimer's Research
Tags Alpha Cognition Partner Content Benzinga
From Benzinga
Alpha Cognition is a Clinical Stage, Biopharmaceutical Company Dedicated to Developing Treatments for Under-served Neurodegenerative Diseases Such as Alzheimer's Dementia
Tags Health Care Biotech Market News
From Benzinga